Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Fleshner

Showing results (241-250 of 266) with videos related to

Pageof 27
Sort By:
Prostate Cancer|June 27, 2022
Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant TissueLinh T Nguyen, Charlotte S Lo, Michael Fyrsta, et al.
Plos Medicine|July 3, 2019
Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker NetworkAndrée-Anne Grosset, Véronique Ouellet, Christine Caron, et al.
BJU International|November 13, 2010
Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional studyCarmen Mir, Shahrokh F Shariat, Theodorus H van der Kwast, et al.
Biopreservation and Biobanking|March 19, 2025
Experts Speak Forum: Decarbonization for Green Biobanking-The Current Landscape and Challenges for the FutureKoh Furuta, Hanh Vu, Daniel Adamek, et al.
European Urology Oncology|April 2, 2019
Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate CancerHanan Goldberg, Abu-Hijlih Ramiz, Rachel Glicksman, et al.
Critical Reviews in Oncology/Hematology|August 30, 2008
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approachJohn M Fitzpatrick, John Anderson, Cora N Sternberg, et al.
The Journal of Urology|September 10, 2025
Reply by AuthorsBernhard J Eigl, Arun Elangovan, Sunita Ghosh, et al.
The Journal of Urology|July 25, 2025
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME StudyBernhard J Eigl, Arun Elangovan, Sunita Ghosh, et al.
BJU International|November 19, 2025
Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancerKeiran J C Pace, Jethro C C Kwong, Harkanwal Randhawa, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2018
Improving patient journey and quality of care: Summary from the second Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meetingWassim Kassouf, Armen Aprikian, Fred Saad, et al.
Pageof 27

Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
Prostate Cancer|June 27, 2022
Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant TissueLinh T Nguyen, Charlotte S Lo, Michael Fyrsta, et al.
Plos Medicine|July 3, 2019
Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker NetworkAndrée-Anne Grosset, Véronique Ouellet, Christine Caron, et al.
BJU International|November 13, 2010
Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional studyCarmen Mir, Shahrokh F Shariat, Theodorus H van der Kwast, et al.
Biopreservation and Biobanking|March 19, 2025
Experts Speak Forum: Decarbonization for Green Biobanking-The Current Landscape and Challenges for the FutureKoh Furuta, Hanh Vu, Daniel Adamek, et al.
European Urology Oncology|April 2, 2019
Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate CancerHanan Goldberg, Abu-Hijlih Ramiz, Rachel Glicksman, et al.
Critical Reviews in Oncology/Hematology|August 30, 2008
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approachJohn M Fitzpatrick, John Anderson, Cora N Sternberg, et al.
The Journal of Urology|September 10, 2025
Reply by AuthorsBernhard J Eigl, Arun Elangovan, Sunita Ghosh, et al.
The Journal of Urology|July 25, 2025
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME StudyBernhard J Eigl, Arun Elangovan, Sunita Ghosh, et al.
BJU International|November 19, 2025
Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancerKeiran J C Pace, Jethro C C Kwong, Harkanwal Randhawa, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2018
Improving patient journey and quality of care: Summary from the second Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meetingWassim Kassouf, Armen Aprikian, Fred Saad, et al.
Pageof 27